|MAP/Aetna Reveal Collaboration: Baby Steps Toward Paradigm Shift?|
|Addiction Treatment Industry Newswire|
01/14/2017 - ATIN - In what could turn
out to be a historic discussion of the central issues facing the addiction
treatment industry, how to take us to the "next level" and finally
rid ourselves of the scourge of "orphan status" within the overall
medical system, Austin-based MAP will be holding a webinar in which a
discussion will be held that will give at least a glimpse of MAP's years long
effort to achieve the industry's long sought after "dream deal" with
a major health insurer. CLICK HEREt to Listen to Webinar
Powerhouse Aetna Behavioral Health on Cutting Edge
Joining in the webinar with MAP CEO Jacob Levenson, who has devoted mission-like dedication to this effort and millions of dollars of the Levenson family fortune, will be two of Aetna Behavioral Health's most prominent executives: Tony Rocchino and Mary I Anderson MD. Mr. Rocchino runs network management at Aetna Behavioral Health and Dr. Anderson is Medical Director, National Accounts CMST at Aetna.
Treatment Leasdership Collaboration on Unprecedented Level?
The Changing Nature of How You Get Paid
The speakers will discuss why collaboration between payor and provider in the form of value-based care is critical for improving clinical and financial outcomes for behavioral health and addiction treatment. In other words, providers are going to see a shift from transactional, fee-for-service pay structure to a quality driven model supported by outcomes that are generally accepted as genuine industrywide. Important in establishing a solid foundation for the success of value-based care will be to ensure that provider, payor and client are all on the same page. And providers must fully understand, and agree upon, the proper definition of value-based care in order that newly defined quality of care standards be consistent and economic for all players large and small.
Explain why Chronic Disease Model Seems More Expensive, But Actually Will be Far Less So
A major part of the discussion will be about how MAP and Aetna have come to be believe that treating addiction as a chronic disease with strong continuums of care - indeed a lifetime of care if necessary in some cases - may seem at first glance to be more expensive. But the webinar will reveal that when in fact the chronic disease model is properly understood, properly executed and widely adopted it will in fact reduce costs dramatically by boosting outcomes and ending the highly expensive "revolving door" of constant readmission of clients into the most expensive acute levels of addiction care.